Insights

Strategic Partnerships Sio Gene Therapies has a track record of forming strategic partnerships, such as the collaboration with Invitae Corporation to offer free genetic testing. This indicates a willingness to work with other companies in the biotechnology space, presenting potential partnership opportunities for sales growth.

Gene Therapy Product Development With a focus on developing gene therapy product candidates, Sio Gene Therapies is actively engaged in cutting-edge research and product innovation. Sales development representatives can explore opportunities to support these development efforts by offering relevant services or technologies to enhance their pipeline.

Key Personnel Changes The recent appointment of David Nassif as interim CEO showcases dynamic leadership at Sio Gene Therapies. This change can signal a shift in strategic direction, presenting an opportunity for sales professionals to engage with new leadership and align offerings with the company's evolving vision.

Clinical-Stage Programs Sio Gene Therapies has launched clinical-stage AAV gene therapy programs for genetic diseases. Sales development representatives can position their products or services to support the advancements in these key programs, potentially leading to collaborations or partnerships.

Market Expansion and Updates The continuous updates and expansions in Sio Gene Therapies' market presence, such as the launch of updates for Parkinson's disease gene therapy, provide indicators of growth and market demand. Sales development professionals can leverage these developments to explore opportunities for collaboration or service provision.

Sio Gene Therapies Tech Stack

Sio Gene Therapies uses 8 technology products and services including Akamai, web-vitals, Office 365, and more. Explore Sio Gene Therapies's tech stack below.

  • Akamai
    Content Delivery Network
  • web-vitals
    Javascript Libraries
  • Office 365
    Office Suites
  • Microsoft Windows Server
    Operating Systems
  • Acquia Cloud Platform
    Platform As A Service
  • HSTS
    Security
  • Akamai Web Application Protector
    Security
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Sio Gene Therapies's Email Address Formats

Sio Gene Therapies uses at least 2 format(s):
Sio Gene Therapies Email FormatsExamplePercentage
First.Last@axovant.comJohn.Doe@axovant.com
98%
FirstMiddle.Last@axovant.comJohnMichael.Doe@axovant.com
2%
First.Last@siogtx.comJohn.Doe@siogtx.com
100%

Frequently Asked Questions

Where is Sio Gene Therapies's headquarters located?

Minus sign iconPlus sign icon
Sio Gene Therapies's main headquarters is located at 11 Times Square New York, New York 10036 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Sio Gene Therapies's stock symbol?

Minus sign iconPlus sign icon
Sio Gene Therapies is a publicly traded company; the company's stock symbol is SIOX.

What is Sio Gene Therapies's official website and social media links?

Minus sign iconPlus sign icon
Sio Gene Therapies's official website is siogtx.com and has social profiles on LinkedIn.

What is Sio Gene Therapies's SIC code NAICS code?

Minus sign iconPlus sign icon
Sio Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sio Gene Therapies have currently?

Minus sign iconPlus sign icon
As of March 2022, Sio Gene Therapies has approximately 67 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. R.Co-Founder: J. I. B.Vice President, Head Of Human Resources & Operations: R. C.. Explore Sio Gene Therapies's employee directory with LeadIQ.

What industry does Sio Gene Therapies belong to?

Minus sign iconPlus sign icon
Sio Gene Therapies operates in the Biotechnology Research industry.

What technology does Sio Gene Therapies use?

Minus sign iconPlus sign icon
Sio Gene Therapies's tech stack includes Akamaiweb-vitalsOffice 365Microsoft Windows ServerAcquia Cloud PlatformHSTSAkamai Web Application ProtectorAcquia Cloud Site Factory.

What is Sio Gene Therapies's email format?

Minus sign iconPlus sign icon
Sio Gene Therapies's email format typically follows the pattern of . Find more Sio Gene Therapies email formats with LeadIQ.

How much funding has Sio Gene Therapies raised to date?

Minus sign iconPlus sign icon
As of March 2022, Sio Gene Therapies has raised $75M in funding. The last funding round occurred on Feb 19, 2020 for $75M.

When was Sio Gene Therapies founded?

Minus sign iconPlus sign icon
Sio Gene Therapies was founded in 2014.
Sio Gene Therapies

Sio Gene Therapies

Biotechnology ResearchNew York, United States51-200 Employees

Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies. 

For more information, visit www.siogtx.com.

Section iconCompany Overview

Headquarters
11 Times Square New York, New York 10036 US
Website
siogtx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SIOX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $75M

    Sio Gene Therapies has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $75M.

Section iconFunding & Financials

  • $75M

    Sio Gene Therapies has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $75M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.